Decoding the immunosuppressive tumour microenvironment of osteosarcoma through single-cell and spatial transcriptomics: implications for targeted therapies and immunotherapies
Unresectable and relapsed osteosarcoma remain difficult to treat. Limited clinical activity of immune checkpoint blockade and early experience with chimeric antigen receptor (CAR) T cells motivate investigation of barriers to effective treatment. Here, we synthesise evidence from single-cell and spatial transcriptomics in a hypothesis-generating narrative review of the tumour microenvironment (TME). We examine myeloid-associated cell states and candidate intercellular communication pathways. We consider their spatial organisation in relation to perfusion and tissue viability, vascular proximity, bone and matrix organisation, and immune accessibility, with attention to anatomical site and treatment history. These overlapping dimensions organise testable questions about how regional features may alter therapeutic access, target engagement and sustained activity. We relate candidate barriers to interventions including B7-H3 antibody–drug conjugates, engineered CAR T cells, myeloid-directed treatment, bone-targeted nanodelivery and rational combinations. The treatment-predictive value of candidate spatial biomarkers requires independent prospective validation. This framework identifies measurable relationships and falsifiable predictions to guide mechanistic studies and future biomarker-informed trials.
Authors
- Yao Dong (ORCID: https://orcid.org/0000-0003-0994-8394)
- Youshu Zhang
- Chuanqiang Dai
- Dexiang Zhang
- Gang Liang
- Yao Zhang
Institutions
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fonc.2026.1940872
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00